22 studies found for:
" August 08, 2007":" September 07, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)
|
||||
| 2 | Completed |
Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
|
||||
| 3 | Completed |
Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection
|
||||
| 4 | Unknown † |
Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
|
||||
| 5 | Unknown † |
HIV Antiretroviral Drugs and Metabolism
|
||||
| 6 | Completed |
Integrase Inhibitor (MK-0518) Viral Decay
|
||||
| 7 | Terminated |
A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
|
||||
| 8 | Completed |
DDI HV (ATV - Merck)
|
||||
| 9 | Completed |
Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
|
||||
| 10 | Unknown † |
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
|
||||
| 11 |
Completed
Has Results |
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
|
||||
| 12 | Active, not recruiting |
Evaluation of Albuminuria HIV-Infected Patients
|
||||
| 13 |
Completed
Has Results |
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)
|
||||
| 14 |
Completed
Has Results |
Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
|
||||
| 15 |
Completed
Has Results |
RAL-eve Study: Raltegravir Substitution Study
|
||||
| 16 | Completed |
Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
|
||||
| 17 |
Terminated
Has Results |
Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI
|
||||
| 18 | Recruiting |
Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
|
||||
| 19 | Completed |
Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
|
||||
| 20 | Withdrawn |
Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma
|
† Indicates status has not been verified in more than two years
